Advertisement
Screener

Tradeweb Markets Inc. (TW) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

Tradeweb Markets Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

Tradeweb Markets Inc. (TW) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-07-30

  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-03-31 was $0.00.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was $1.60M, a 23.08% increase year-over-year.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $3.80M.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $10.80M, a 730.77% increase from fiscal 2024.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $1.30M, a 88.29% decline from fiscal 2023.
  • Tradeweb Markets Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $11.10M.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2026-06-30$0.00
10-Q · filed 2026-07-30
$0.00
10-Q · filed 2026-07-30
$1.60M
derived: sum of 3 quarters · filed 2026-07-30
$5.40M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$0.00
10-Q · filed 2026-04-29
$1.60M
derived: sum of 2 quarters · filed 2026-04-29
$5.40M
derived: sum of 3 quarters · filed 2026-04-29
$10.80M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05
$5.40M
derived: sum of 2 quarters · filed 2026-02-05
$10.80M
derived: sum of 3 quarters · filed 2026-07-30
$10.80M
10-K · filed 2026-02-05
2025-09-30$3.80M
10-Q · filed 2025-10-30
$9.20M
derived: sum of 2 quarters · filed 2026-07-30
$9.20M
10-Q · filed 2025-10-30
$10.50M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$5.40M
10-Q · filed 2026-07-30
$5.40M
10-Q · filed 2026-07-30
$6.70M
derived: sum of 3 quarters · filed 2026-07-30
$6.70M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$0.00
10-Q · filed 2026-04-29
$1.30M
derived: sum of 2 quarters · filed 2026-04-29
$1.30M
derived: sum of 3 quarters · filed 2026-04-29
$1.30M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05
$1.30M
derived: sum of 2 quarters · filed 2026-02-05
$1.30M
derived: sum of 3 quarters · filed 2026-02-05
$1.30M
10-K · filed 2026-02-05
2024-09-30$0.00
10-Q · filed 2025-10-30
$0.00
derived: sum of 2 quarters · filed 2025-10-30
$0.00
10-Q · filed 2025-10-30
2024-06-30$0.00
10-Q · filed 2025-07-30
$0.00
10-Q · filed 2025-07-30
2023-12-31$11.10M
10-K · filed 2026-02-05